Award
National Cancer Institute 5R01CA266699-05
Targeting SUMO1 degradation for advanced colon cancer therapy
Recipient
Anita Bellail
Award Amount
$356,986.00
Ceiling
$356,986.00
Awarded
June 16, 2026
Identifier
5R01CA266699-05
Award for research and development in cancer therapy focusing on SUMO1 degradation for advanced colon cancer treatment.
Description
This project aims to develop SUMO1 degraders as novel anticancer agents for advanced colon cancer, including in vivo toxicity testing, mechanism studies, and combination therapy evaluations.